20185191

Source:http://linkedlifedata.com/resource/pubmed/id/20185191

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003451, umls-concept:C0243071, umls-concept:C0328104, umls-concept:C0332152, umls-concept:C0332157, umls-concept:C0524909, umls-concept:C0971023, umls-concept:C1280500
pubmed:issue	4
pubmed:dateCreated	2010-3-29
pubmed:abstractText	Entecavir is a potent inhibitor of viral replication in nucleos(t)ide analogue (NA)-naïve chronic hepatitis B patients, but data on the efficacy in NA-experienced subjects are limited.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8503886
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Guanine, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/adefovir, http://linkedlifedata.com/resource/pubmed/chemical/entecavir
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0168-8278
pubmed:author	pubmed-author:ButiMariaM, pubmed-author:DeterdingKatjaK, pubmed-author:HansenBettina EBE, pubmed-author:JanssenHarry L AHL, pubmed-author:PetersenJörgJ, pubmed-author:ReijndersJurriën G PJG, pubmed-author:SantantonioTeresaT, pubmed-author:VIRGIL Surveillance Study Group, pubmed-author:WedemeyerHeinerH, pubmed-author:ZoulimFabienF, pubmed-author:van BömmelFlorianF
pubmed:issnType	Print
pubmed:volume	52
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	493-500
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20185191-Adenine, pubmed-meshheading:20185191-Adult, pubmed-meshheading:20185191-Antiviral Agents, pubmed-meshheading:20185191-Drug Resistance, Viral, pubmed-meshheading:20185191-Female, pubmed-meshheading:20185191-Follow-Up Studies, pubmed-meshheading:20185191-Guanine, pubmed-meshheading:20185191-Hepatitis B, Chronic, pubmed-meshheading:20185191-Hepatitis B e Antigens, pubmed-meshheading:20185191-Hepatitis B virus, pubmed-meshheading:20185191-Humans, pubmed-meshheading:20185191-Kaplan-Meier Estimate, pubmed-meshheading:20185191-Lamivudine, pubmed-meshheading:20185191-Male, pubmed-meshheading:20185191-Middle Aged, pubmed-meshheading:20185191-Phosphonic Acids, pubmed-meshheading:20185191-Proportional Hazards Models, pubmed-meshheading:20185191-Prospective Studies, pubmed-meshheading:20185191-Reverse Transcriptase Inhibitors, pubmed-meshheading:20185191-Virus Replication
pubmed:year	2010
pubmed:articleTitle	Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
pubmed:affiliation	Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Gravendijkwal 230, Room Ha 204, Rotterdam, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study